BioCatalystWatch
TLSAWorkspace / TLSA / OverviewCompany library
Tiziana Life Sciences Ltd logo

Tiziana Life Sciences Ltd

Tiziana Life Sciences Ltd (TLSA)

Website

Price
Market cap
Next catalystExpected 2026Foralumab — early/mild Alzheimer’s disease · Phase 2 dataCompany release ↗
Cash

Chart & Events

Candle interval

Core Clinical

Foralumab

CD3

PreINDP1P2P3FilingApproved
Upcoming / outlook

Foralumab

CD3

PreINDP1P2P3FilingApproved
Upcoming / outlook

  • Timing and evidence

Foralumab

CD3

PreINDP1P2P3FilingApproved
Upcoming / outlook

Technology Summary

Scientific context

Detailed technology interpretation

Technology advantages

Representative pipeline applications

Disease and market context

Detailed science focus

Background, answer, next evidence

Clinical

Upcoming clinical milestones

Foralumab

CD3

PreINDP1P2P3FilingApproved
Upcoming / outlook

  • Timing and evidence

Foralumab

CD3

PreINDP1P2P3FilingApproved
Upcoming / outlook

Foralumab

CD3

PreINDP1P2P3FilingApproved
Upcoming / outlook

Other pipelines

Foralumab

CD3

PreINDP1P2P3FilingApproved
Foralumab

CD3

Foralumab

CD3

Foralumab

CD3

Foralumab

CD3

Foralumab

CD3

PreINDP1P2P3FilingApproved

History / paused

Foralumab

CD3

PreINDP1P2P3FilingApproved
Foralumab

CD3

CDK1 × CDK2 × CDK4 × CDK5 × CDK7 × TRKs × Src family kinases

PreINDP1P2P3FilingApproved

CDK1 × CDK2 × CDK4 × CDK5 × CDK7 × TRKs × Src family kinases

PreINDP1P2P3FilingApproved

IL-6R × Membrane-bound IL-6R × Soluble IL-6R

IND

PreINDP1P2P3FilingApproved

IL-6R × Membrane-bound IL-6R × Soluble IL-6R

Financial position

Cash and cash equivalents

Source and basis

Short-term investments

Net operating cash flow

Source and basis

Company funding outlook

Upcoming milestones

Financial history

Amounts and sources
PeriodCashCurrent investmentsOperatingInvestingFinancing

PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

Annual trends

Reported item

Reported shares and borrowings

Ownership and institutions

Status

Market Reaction / Supply Context

Market Structure

TLSA PR & News

PR & News

TLSA SEC archive